ENGIE teams up with Cipher Mining to power Texas data center
The new arrangement would leverage the wind project's renewable energy generation to power the co-located data center, helping to alleviate an already congested transmission area. This helps offset basis risk and mitigate curtailment challenges especially in regions like West Texas, where wind and solar resources are abundant but often face constraints due to transmission bottlenecks and curtailment.
By pairing the data center with renewable energy, this strategic collaboration supports the use of surplus energy during periods of excess generation, while enhancing grid stability and reliability.
"ENGIE is committed to pursuing innovative solutions that maximize the value of renewable generation and improving cost effectiveness of delivering clean energy supply to our customers," said David Carroll, Chief Renewables Officer & SVP, ENGIE North America. "We are focused on meeting the growing need for power by our customers as they expand their operations in the U.S. and renewables is an essential part of supplying this increasing demand."
This agreement continues to reflect ENGIE's position as one of the leading providers of power purchase agreements globally.
About ENGIE North AmericaBased in Houston, Texas, ENGIE North America Inc. is a regional hub of ENGIE, a major player in the energy transition, whose purpose is to accelerate the transition towards a carbon-neutral economy. With 98,000 employees in 30 countries, the Group covers the entire energy value chain, from production to infrastructures and sales. ENGIE combines complementary activities: renewable electricity and green gas production, flexibility assets (notably batteries), gas and electricity transmission and distribution networks, local energy infrastructures (heating and cooling networks) and the supply of energy to local authorities and businesses. Every year, ENGIE invests more than €10 billion to drive forward the energy transition and achieve its net zero carbon goal by 2045. ENGIE (ENGI), is listed on the Paris and Brussels Stock Exchanges. For more information on ENGIE in North America, please visit our website at www.engie-na.com or our LinkedIn page at www.linkedin.com/company/engie-north-america-inc.
Contact:ENGIE North AmericaMichael Clingan, External RelationsMichael.clingan@external.engie.com832-745-6057
View original content to download multimedia:https://www.prnewswire.com/news-releases/engie-teams-up-with-cipher-mining-to-power-texas-data-center-302454171.html
SOURCE Engie North America Inc.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Reborn Coffee Expands Globally, Eyes Blockchain For Future-Proof Financial Management
Reborn Coffee Inc. (NASDAQ:REBN) shares surged Monday after the company unveiled a major initiative: a review of blockchain-based digital asset strategies. The California-based specialty coffee chain said it is assessing how regulated digital assets could be used to enhance treasury management, payments, and customer engagement. CEO Jay Kim said the review reflects the company's push for 'forward-looking, responsible treasury practices' aimed at strengthening its financial emphasized that no agreements have been made, and any use of digital assets would require board approval and full compliance with U.S. Securities and Exchange Commission rules, Globe Newswire reports. Just days earlier, Reborn signed a $1 million licensing deal with Reborn Korea Co., Ltd. to launch retail operations in South Korea, the world's third-largest coffee-consuming country on a per capita basis. The flagship store is set to open this fall in Seoul's Gwanghwamun district. The three-story location will feature a café, roasting lab, training center, and office space with rooftop views of historic landmarks. Following the flagship opening, Reborn Korea plans additional stores in Gwangjin, Nami Island, and Bundang, with nationwide expansion to follow. The brand's signature sprouted coffee and bakery concepts will anchor the rollout while attracting franchise opportunities. The South Korean move follows Reborn Coffee's recent market entries in the Middle East, China, Georgia, and Armenia. Management views the expansion as a milestone in its global strategy, pairing international growth with innovation in financial management. The Consumer Discretionary Select Sector SPDR Fund (NYSE:XLY) and the Global X MSCI China Consumer Discretionary ETF (NYSE:CHIQ) offer broader exposure to retail and innovation themes. Price Action: At last check Monday, REBN shares were trading higher by 7.33% to $3.200. Read Next:Image by Funtap via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Reborn Coffee Expands Globally, Eyes Blockchain For Future-Proof Financial Management originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 minutes ago
- Yahoo
Here's What Made Atai Capital Management Sell AstroNova (ALOT)
Atai Capital Management, an investment management firm, recently released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 32.8% in the second quarter, net of all fees, bringing the YTD returns to 29.4% net of all fees. This is compared to a 10.9% total return for the S&P 500, an 8.5% total return for the Russell 2000, and a 15.5% total return for the Russell Microcap for the quarter and 6.2%, -1.8% and -1.1%, respectively, for YTD. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Atai Capital Management highlighted stocks such as AstroNova, Inc. (NASDAQ:ALOT). AstroNova, Inc. (NASDAQ:ALOT) develops and manufactures specialty printers and data acquisition and analysis systems. The one-month return of AstroNova, Inc. (NASDAQ:ALOT) was -0.27%, and its shares lost 22.17% of their value over the last 52 weeks. On August 15, 2025, AstroNova, Inc. (NASDAQ:ALOT) stock closed at $11.27 per share with a market capitalization of $85.61 million. Atai Capital Management stated the following regarding AstroNova, Inc. (NASDAQ:ALOT) in its second quarter 2025 investor letter: "We first detailed our thesis on AstroNova, Inc. (NASDAQ:ALOT) in our Q1-2023 letter and have provided numerous updates in subsequent letters. In short, our investment was predicated on the view that AstroNova was a low-risk "under-earner" with an obvious path for earnings to normalize significantly higher. A technician editing complex data acquisition systems in an analytical workspace. AstroNova, Inc. (NASDAQ:ALOT) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 3 hedge fund portfolios held AstroNova, Inc. (NASDAQ:ALOT) at the end of the first quarter, which was 3 in the previous quarter. In the fiscal first quarter of 2026, AstroNova, Inc.'s (NASDAQ:ALOT) reported revenue of $37.7 million, grew 14.4% year over year and 0.9% sequentially. While we acknowledge the potential of AstroNova, Inc. (NASDAQ:ALOT) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered AstroNova, Inc. (NASDAQ:ALOT) and shared Atai Capital Management's views on the company in the previous quarter. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
12 minutes ago
- Associated Press
Apollo Biowellness, Inc., Corporate Update
North Bergen, New Jersey--(Newsfile Corp. - August 18, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the 'Company'), is pleased to announce that it has been approved to file on OTCIQ. The Company is also providing the following updates. [ This image cannot be displayed. Please visit the source: ] To view an enhanced version of this graphic, please visit: The Company is in final negotiations with an Israeli based Bio-Tech and Biologics manufacturer, listed on NASDAQ, for the co-development of our shelf-stable biologic cosmetic, which is planned to be launched in the 4 th Quarter of 2025. The shelf-stable biologic cosmetic is to be known as Ceilo Skin Care, and will be sold through retail, direct-to-consumer and e-commerce platforms. In addition, the Company is in negotiations with a large aesthetic company in the business of Laser Energy Devices and products that are marketed and sold to Plastic Surgeons, Dermatologists, Med Spa's and Aesthetic Clinicians. The negotiations are for the purpose of a business combination or potential merger to create a combination therapy company, where we will sell Biologics and Aesthetic devices hand-in-glove. Also, before the end of the 3 rd Quarter of 2025, Apollo will launch the first of its kind Pet and Veterinarian Biologic, using exosomes and placental products, for Pets, via a Doctor branded product, sold exclusively through licensed Veterinarians, Clinicians and Pet Professionals. This product will be using 100% natural biologic products to treat pets for arthritis issues, joint issues, inflammation issues and skin issues. Our product will include topical and injectable therapeutics. The Company will be releasing more details as they become relevant regarding these events in the days and weeks to come, and in parallel with these actions, the Company is also working with its Debt Holders and Convertible Note Holders to either restructure, refinance or convert the majority of the positions to a preferred class of equity. This is line with the plan of management to coordinate financing for the Company to allow the plans for growth for the next 12 months. James W. Zimbler, President and CEO, stated, 'I am very eager for the new start for our biologic products company, along with the potential for new areas of activity. I anticipate an exciting next 12 months for the Company.' The Company uses the following handle on X at @ApolloBioKOAN to communicate with its shareholders About Apollo Biowellness, Inc. Apollo Biowellness, Inc., and its subsidiary, Evolutionary Biologics, Inc., is engaged in the discovery, development and marketing of products designed to better mankind. We believe we are positioning our company as a leader in the field of Regenerative Medicine as defined by the National Institute of Health using biologic based products. Intended products are to be marketed under third-party label exemptions. We are focusing our current efforts on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. Also, we are licensed under a patent-pending application to market a dual acting all-natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Products are being developed for consumer and professional markets. Before using any of our products, you should always consult with your veterinarian and/or family doctor. Forward-Looking StatementsCorporate Contact James W. Zimbler President/CEO/Director [email protected] 631-806-1420 X at @ApolloBioKOAN To view the source version of this press release, please visit
